WO2009004390A2 - Improved incapacitant spray - Google Patents

Improved incapacitant spray Download PDF

Info

Publication number
WO2009004390A2
WO2009004390A2 PCT/GB2008/050543 GB2008050543W WO2009004390A2 WO 2009004390 A2 WO2009004390 A2 WO 2009004390A2 GB 2008050543 W GB2008050543 W GB 2008050543W WO 2009004390 A2 WO2009004390 A2 WO 2009004390A2
Authority
WO
WIPO (PCT)
Prior art keywords
incapacitant
mixture
per cent
proportion
weight
Prior art date
Application number
PCT/GB2008/050543
Other languages
French (fr)
Other versions
WO2009004390A3 (en
Inventor
Eran Bauer
Gerard Bauer
Wayne Morris
Original Assignee
Eran Bauer
Gerard Bauer
Wayne Morris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eran Bauer, Gerard Bauer, Wayne Morris filed Critical Eran Bauer
Priority to EP08776178A priority Critical patent/EP2176198B8/en
Publication of WO2009004390A2 publication Critical patent/WO2009004390A2/en
Publication of WO2009004390A3 publication Critical patent/WO2009004390A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C06—EXPLOSIVES; MATCHES
    • C06D—MEANS FOR GENERATING SMOKE OR MIST; GAS-ATTACK COMPOSITIONS; GENERATION OF GAS FOR BLASTING OR PROPULSION (CHEMICAL PART)
    • C06D7/00—Compositions for gas-attacks

Definitions

  • This invention relates to incapacitants, and in particular to incapacitant sprays used in law enforcement.
  • Incapacitants containing pelargonyl vanillylamide (PAVA) as the primary incapacitant are known from GB2337806. Such incapacitants have been developed using carriers comprising mixtures of alcohol and water to solubilise the PAVA. These incapacitants function by inducing temporary blindness when the mixture enters the eyes without causing injury to the skin or mucous membranes of an individual. Whilst some tears may be produced as a side effect of the incapacitant entering the eyes, it is not the production of tears which causes temporary blindness. Blindness results from intense pain in the eyes which causes the eyelids to close involuntarily rendering the person blind until such time as the effect of the incapacitant wears off.
  • PAVA pelargonyl vanillylamide
  • incapacitant mixtures are susceptible to freezing at temperatures below 2 0 C. Incapacitant sprays using this mixture are therefore of limited use in cold weather or in countries with a cold climate.
  • the invention provides an incapacitant mixture comprising PAVA and a carrier, wherein the mixture induces temporary blindness and/or irritation in the mucus membranes in a human or animal, wherein the carrier is miscible with water and has a boiling point greater than that of water, and wherein PAVA is the primary incapacitant in the mixture, the proportion of PAVA in the mixture being 0.65 per cent or less.
  • PAVA refers to pelargonic acid vannillylamide classified under CAS No. 2444-46-4.
  • the proportion of PAVA in the mixture is 0.65 per cent or less by weight. More preferably, the proportion of PAVA is between 0.3 and 0.65 per cent by weight. Still more preferably, the proportion of PAVA is between 0.3 and 0.6 per cent by weight.
  • the carrier is a glycol or glycerine.
  • the proportion of the glycol or glycerine in the mixture is 50 per cent or more by weight. More preferably the proportion of the glycol or glycerine in the mixture is 60 per cent or more by weight. Still more preferably the proportion of glycol or glycerine in the mixture is 72 per cent by weight.
  • Suitable glycols include any edible glycols from the glycol family, for example ethylene glycol or propylene glycol.
  • the carrier is propylene glycol.
  • the proportion of propylene glycol in the mixture is 50 per cent or more by weight. More preferably the proportion of propylene glycol in the mixture is 60 per cent or more by weight. More preferably the proportion of propylene glycol is between 65 and 90 per cent. Still more preferably, the proportion of propylene glycol is between 65 and 80 per cent by weight. Still more preferably, the proportion of propylene glycol is 72 per cent by weight.
  • the mixture further comprises water.
  • the proportion of water in the mixture 30 per cent or less by weight. More preferably, the proportion of water is between 20 and 30 per cent by weight. Still more preferably, the proportion of water in the mixture is 25 per cent by weight.
  • the mixture further comprises an alcohol. Any suitable alcohol may be used.
  • the alcohol is selected from the group comprising ethanol, propanol and isopropanol.
  • the proportion of alcohol is 25 per cent or less by weight. More preferably, the proportion of alcohol is between 1.0 and 3.5 per cent by weight. Still more preferably, the proportion of alcohol is between 1.0 and 3.0 per cent by weight. Still more preferably the proportion of alcohol is 2.7 per cent by weight.
  • the mixture is capable of inducing temporary blindness and/or irritation in the mucus membranes in a human, and more preferably the mixture is capable of inducing blindness and/or irritation in the mucus membranes in a human for more than 5 minutes.
  • the mixture is a liquid between the temperatures of -2O 0 C and +5O 0 C.
  • the mixture may comprise a dye or a marker or a UV dye or an Infrared dye or an optical brightener or a synthetic DNA tag.
  • a synthetic DNA tag allows a sprayed individual to be linked to a particular batch of incapacitant spray.
  • One embodiment of the invention provides an incapacitant spray comprising a means for storing and delivering an incapacitant mixture according to the invention.
  • the storing means may be a can or a container.
  • the delivery means may be an aerosol, the mixture of the invention comprising an aerosol propellant, such as nitrogen, carbon dioxide, 1,1,1,2-tetrafiuoro ethane (classified under CAS No, 811-97-2), dimethyl ether, butane, propane or oxygen.
  • an aerosol propellant such as nitrogen, carbon dioxide, 1,1,1,2-tetrafiuoro ethane (classified under CAS No, 811-97-2), dimethyl ether, butane, propane or oxygen.
  • the propellant is nitrogen.
  • the delivery means may use pressurised air to expel the mixture of the invention form the storing means.
  • the delivery means preferably includes a nozzle.
  • an incapacitant mixture comprising 0.3 per cent PAVA; a carrier being 72 per cent propylene glycol; 25 per cent water and 2.7 per cent ethanol, all by weight, and propellant therefor, the said propellant being nitrogen.
  • PAVA in any overspray remains in solution for a longer period of time and can be easily cleaned by simply wiping away and this lessens the effect of cross-contamination.
  • Glycerine, and glycols for example propylene glycol
  • Adding a proportion of an alcohol, for example ethanol, to a glycol or a glycol/water mixture lowers the surface tension of that mixture.
  • a spray may be broken up into droplets.
  • the size of the resulting droplets increases with the surface tension of the liquid.
  • the incapacitant mixture of the invention has a higher surface tension than known incapacitant mixtures comprising with an alcohol and water based solvent.
  • the incapacitant mixture of the invention will therefore will break up into larger droplet sizes. This is illustrated in the following examples: a) An incapacitant mixture having 0.3 per cent PAVA and a solvent comprising
  • Droplet size distribution was measured from repeated short bursts of the mixture from a canister placed at distances of 1.0m, 2.0m and 3.0m from the measurement location. On average it was found that 79% of droplets resulting from the spray had a diameter of more than 10 micron.
  • An incapacitant mixture according to the invention having 0.3 per cent
  • PAVA 72.0 per cent propylene glycol, 25.0 per cent water and 2.7 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
  • Droplet size distribution was measured from repeated short bursts of the mixture from a canister placed at distances of 1.0m, 2.0m and 3.0m from the measurement location. On average it was found that 99.18 per cent of droplets resulting from the spray had a diameter of more than 10 micron.
  • Droplet sizes of more than 10 micron are unlikely to be inhaled into the human respiratory system in significant quantity. Inhalation of an incapacitant mixture causes a cough reflex response.
  • the incapacitant mixture of the invention therefore provides a reduced cough reflex response compared to known incapacitant sprays.
  • the mixture of the invention does not have any significant effect on the respiratory system, yet causes temporary blindness which is exceptionally effective in incapacitating humans. The person must be incapacitated during the journey to a police station for instance until he is locked in a cell. A person may be dosed repeatedly with the incapacitant of the invention, in order to keep him under control when the effects of one application begin to wear off.
  • blindness results from intense pain in the eyes which causes the eyelids to close involuntarily rendering the person blind until such time as the effect of the incapacitant wears off.
  • incapacitation resulting from irritation to the mucus membranes this is also a result of intense pain, felt in areas exposed skin covered with mucus membranes and immediately adjacent such areas of skin.
  • the incapacitant is prevented from entering the eyes, the person may nevertheless be incapacitated by intense pain in and around the nose and mouth.
  • the incapacitant mixture of the invention does not have any significant effect on the respiratory system. Whilst the mixture causes the tear ducts to swell and some tears to be produced, these are a side effect. Intense lachrymation is not the cause of incapacitation.
  • An incapacitant mixture according to the invention having 0.3 per cent PAVA, 72.0 per cent propylene glycol, 25.0 per cent water and 2.7 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
  • the incapacitant mixture had a surface tension similar to that of water.
  • the incapacitant mixture was sprayed at a person in the region of the eyes.
  • the incapacitant caused irritation of the eyes, thereby incapacitating the said person.
  • the eyes watered in connection with the irritation caused by the incapacitant.
  • An incapacitant mixture according to the invention having 0.3 per cent PAVA, 73.7 per cent propylene glycol, 25.0 per cent water and 1.0 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
  • the incapacitant mixture was sprayed at a person in the region of the eyes.
  • the incapacitant caused irritation of the eyes, thereby incapacitating the said person.
  • the eyes watered in connection with the irritation caused by the incapacitant.
  • the incapacitant mixture was also sprayed at a person wearing protective goggles, directly at the nose and mouth.
  • the incapacitant caused irritation of the mucus membranes and intense pain in the mouth and nose, thereby incapacitating the said person. Even though the incapacitant is not sprayed into the eyes, the eyes may nevertheless water in connection with the irritation caused by the incapacitant.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Combustion & Propulsion (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An incapacitant mixture which induces temporary blindness in a human or animal comprises pelargonyl vanillylamide and a carrier. The carrier is miscible with water and has a boiling point greater than that of water. PAVA is the primary incapacitant in the mixture and the proportion of PAVA in the mixture is 0.65 per cent or less.

Description

IMPROVED INCAPACITANT SPRAY
Field of the Invention
This invention relates to incapacitants, and in particular to incapacitant sprays used in law enforcement.
Background to the Invention
Incapacitants containing pelargonyl vanillylamide (PAVA) as the primary incapacitant are known from GB2337806. Such incapacitants have been developed using carriers comprising mixtures of alcohol and water to solubilise the PAVA. These incapacitants function by inducing temporary blindness when the mixture enters the eyes without causing injury to the skin or mucous membranes of an individual. Whilst some tears may be produced as a side effect of the incapacitant entering the eyes, it is not the production of tears which causes temporary blindness. Blindness results from intense pain in the eyes which causes the eyelids to close involuntarily rendering the person blind until such time as the effect of the incapacitant wears off.
Such incapacitant mixtures have an evaporation rate greater than that of water. When an incapacitant spray is used it is inevitable that some overspray will occur. When the solvent evaporates, neat PAVA is left behind and this causes problems with cross contamination.
It has also been shown that such incapacitant mixtures are susceptible to freezing at temperatures below 20C. Incapacitant sprays using this mixture are therefore of limited use in cold weather or in countries with a cold climate.
It has also been shown that in windy conditions such incapacitant mixtures can break up into small, sub-micron size droplets. Sub-micron size droplets are more likely to cross the skin or enter the lungs.
It has also been shown that such incapacitant mixtures can break up into small, sub- micron size droplets on impact which can rebound from the person being sprayed. This can be a problem for bystanders in confined spaces such as custody suites or inside vehicles. It would therefore be desirable to provide an improved incapacitant for use by police forces, peace-keeping forces, the military and also for personal use. Summary of the Invention
The invention provides an incapacitant mixture comprising PAVA and a carrier, wherein the mixture induces temporary blindness and/or irritation in the mucus membranes in a human or animal, wherein the carrier is miscible with water and has a boiling point greater than that of water, and wherein PAVA is the primary incapacitant in the mixture, the proportion of PAVA in the mixture being 0.65 per cent or less.
The term PAVA, used throughout the specification, refers to pelargonic acid vannillylamide classified under CAS No. 2444-46-4.
Preferably, the proportion of PAVA in the mixture is 0.65 per cent or less by weight. More preferably, the proportion of PAVA is between 0.3 and 0.65 per cent by weight. Still more preferably, the proportion of PAVA is between 0.3 and 0.6 per cent by weight.
Preferably the carrier is a glycol or glycerine. Preferably the proportion of the glycol or glycerine in the mixture is 50 per cent or more by weight. More preferably the proportion of the glycol or glycerine in the mixture is 60 per cent or more by weight. Still more preferably the proportion of glycol or glycerine in the mixture is 72 per cent by weight. Suitable glycols include any edible glycols from the glycol family, for example ethylene glycol or propylene glycol. Preferably the carrier is propylene glycol. Preferably the proportion of propylene glycol in the mixture is 50 per cent or more by weight. More preferably the proportion of propylene glycol in the mixture is 60 per cent or more by weight. More preferably the proportion of propylene glycol is between 65 and 90 per cent. Still more preferably, the proportion of propylene glycol is between 65 and 80 per cent by weight. Still more preferably, the proportion of propylene glycol is 72 per cent by weight.
Preferably the mixture further comprises water. Preferably the proportion of water in the mixture 30 per cent or less by weight. More preferably, the proportion of water is between 20 and 30 per cent by weight. Still more preferably, the proportion of water in the mixture is 25 per cent by weight. Preferably the mixture further comprises an alcohol. Any suitable alcohol may be used. Preferably the alcohol is selected from the group comprising ethanol, propanol and isopropanol. Preferably the proportion of alcohol is 25 per cent or less by weight. More preferably, the proportion of alcohol is between 1.0 and 3.5 per cent by weight. Still more preferably, the proportion of alcohol is between 1.0 and 3.0 per cent by weight. Still more preferably the proportion of alcohol is 2.7 per cent by weight.
Preferably, the mixture is capable of inducing temporary blindness and/or irritation in the mucus membranes in a human, and more preferably the mixture is capable of inducing blindness and/or irritation in the mucus membranes in a human for more than 5 minutes.
Preferably, the mixture is a liquid between the temperatures of -2O0C and +5O0C.
The mixture may comprise a dye or a marker or a UV dye or an Infrared dye or an optical brightener or a synthetic DNA tag. A synthetic DNA tag allows a sprayed individual to be linked to a particular batch of incapacitant spray.
One embodiment of the invention provides an incapacitant spray comprising a means for storing and delivering an incapacitant mixture according to the invention.
The storing means may be a can or a container.
The delivery means may be an aerosol, the mixture of the invention comprising an aerosol propellant, such as nitrogen, carbon dioxide, 1,1,1,2-tetrafiuoro ethane (classified under CAS No, 811-97-2), dimethyl ether, butane, propane or oxygen. Preferably the propellant is nitrogen. Alternatively, the delivery means may use pressurised air to expel the mixture of the invention form the storing means.
The delivery means preferably includes a nozzle. In one embodiment of the invention there is provided an incapacitant mixture comprising 0.3 per cent PAVA; a carrier being 72 per cent propylene glycol; 25 per cent water and 2.7 per cent ethanol, all by weight, and propellant therefor, the said propellant being nitrogen.
When an incapacitant spray is used in confined conditions it is inevitable that some overspray will occur. Substances with a boiling point which is greater than 1000C tend to have a slower evaporation rate than water. Propylene glycol, for example, has a boiling point of 187 0C and also has a very slow evaporation rate, slower than that of water. Ethanol has a boiling point of 780C and has a much higher evaporation rate than water. As a result of this the incapacitant mixture of the invention has a much slower evaporation rate than an equivalent mixture with an alcohol/water based solvent. This is of great advantage as the
PAVA in any overspray remains in solution for a longer period of time and can be easily cleaned by simply wiping away and this lessens the effect of cross-contamination. Glycerine, and glycols, for example propylene glycol, have a higher surface tension than water, which in turn has a higher surface tension than an alcohol. Adding a proportion of an alcohol, for example ethanol, to a glycol or a glycol/water mixture lowers the surface tension of that mixture. It may be desirable to provide an incapacitant mixture with a lower surface tension. For example if an incapacitant spray is sprayed above the eyes of a person it may be desirable that the surface tension of the mixture is low enough to allow the mixture to run down into the eyes. This can be achieved by the addition of an alcohol to the mixture.
In windy conditions, or on impact with a surface, a spray may be broken up into droplets. The size of the resulting droplets increases with the surface tension of the liquid. The incapacitant mixture of the invention has a higher surface tension than known incapacitant mixtures comprising with an alcohol and water based solvent. The incapacitant mixture of the invention will therefore will break up into larger droplet sizes. This is illustrated in the following examples: a) An incapacitant mixture having 0.3 per cent PAVA and a solvent comprising
50 per cent ethanol and 50 per cent water, and nitrogen as propellant was prepared.
Droplet size distribution was measured from repeated short bursts of the mixture from a canister placed at distances of 1.0m, 2.0m and 3.0m from the measurement location. On average it was found that 79% of droplets resulting from the spray had a diameter of more than 10 micron. b) An incapacitant mixture according to the invention having 0.3 per cent
PAVA, 72.0 per cent propylene glycol, 25.0 per cent water and 2.7 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
Droplet size distribution was measured from repeated short bursts of the mixture from a canister placed at distances of 1.0m, 2.0m and 3.0m from the measurement location. On average it was found that 99.18 per cent of droplets resulting from the spray had a diameter of more than 10 micron.
Droplet sizes of more than 10 micron are unlikely to be inhaled into the human respiratory system in significant quantity. Inhalation of an incapacitant mixture causes a cough reflex response. The incapacitant mixture of the invention therefore provides a reduced cough reflex response compared to known incapacitant sprays. The mixture of the invention does not have any significant effect on the respiratory system, yet causes temporary blindness which is exceptionally effective in incapacitating humans. The person must be incapacitated during the journey to a police station for instance until he is locked in a cell. A person may be dosed repeatedly with the incapacitant of the invention, in order to keep him under control when the effects of one application begin to wear off.
Blindness results from intense pain in the eyes which causes the eyelids to close involuntarily rendering the person blind until such time as the effect of the incapacitant wears off. In the case of incapacitation resulting from irritation to the mucus membranes this is also a result of intense pain, felt in areas exposed skin covered with mucus membranes and immediately adjacent such areas of skin. Hence, if for some reason the incapacitant is prevented from entering the eyes, the person may nevertheless be incapacitated by intense pain in and around the nose and mouth. However, due to the comparatively large droplet size the incapacitant mixture of the invention does not have any significant effect on the respiratory system. Whilst the mixture causes the tear ducts to swell and some tears to be produced, these are a side effect. Intense lachrymation is not the cause of incapacitation.
Examples
1. An incapacitant mixture according to the invention having 0.3 per cent PAVA, 72.0 per cent propylene glycol, 25.0 per cent water and 2.7 per cent ethanol (all by weight), and nitrogen as a propellant was prepared. The incapacitant mixture had a surface tension similar to that of water.
The incapacitant mixture was sprayed at a person in the region of the eyes. The incapacitant caused irritation of the eyes, thereby incapacitating the said person. The eyes watered in connection with the irritation caused by the incapacitant.
2. An incapacitant mixture according to the invention having 0.3 per cent PAVA, 73.7 per cent propylene glycol, 25.0 per cent water and 1.0 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
The incapacitant mixture was sprayed at a person in the region of the eyes. The incapacitant caused irritation of the eyes, thereby incapacitating the said person. The eyes watered in connection with the irritation caused by the incapacitant. The incapacitant mixture was also sprayed at a person wearing protective goggles, directly at the nose and mouth. The incapacitant caused irritation of the mucus membranes and intense pain in the mouth and nose, thereby incapacitating the said person. Even though the incapacitant is not sprayed into the eyes, the eyes may nevertheless water in connection with the irritation caused by the incapacitant.
With a concentration of 1.0 per cent ethanol the incapacitant mixture had a higher surface tension compared to water.

Claims

Claims
1. An incapacitant mixture comprising PAVA and a carrier, wherein the mixture induces temporary blindness and/or irritation in the mucus membranes in a human or animal, wherein the carrier is miscible with water and has a boiling point greater than that of water, and wherein PAVA is the primary incapacitant in the mixture, the proportion of PAVA in the mixture being 0.65 per cent or less.
2. An incapacitant mixture according to claim 1, wherein the proportion of PAVA in the mixture is 0.65 per cent or less by weight. 3. An incapacitant mixture according to claim 2, wherein the proportion of PAVA in the mixture is between 0.
3 and 0.65 per cent by weight.
4. An incapacitant mixture according to claim 3, wherein the proportion of PAVA in the mixture is between 0.3 and 0.6 per cent by weight.
5. An incapacitant mixture according to any preceding claim, wherein the carrier is glycerine.
6. An incapacitant mixture according to any of claims 1 to 4, wherein the carrier is a glycol.
7. An incapacitant mixture according to claim 5 or 6, wherein the proportion of carrier in the mixture is 50 per cent or more by weight.
8. An incapacitant mixture according to claim 7, wherein the proportion of carrier in the mixture is 60 per cent or more by weight.
9. An incapacitant mixture according to claim 8, wherein the proportion of carrier in the mixture is 72 per cent by weight.
10. An incapacitant mixture according to any of claims 6-9, wherein the carrier is propylene glycol.
11. An incapacitant mixture according to any preceding claim, further comprising water in a proportion of 30 per cent or less by weight.
12. An incapacitant mixture according to claim 11, wherein the proportion of water in the mixture is between 20 and 30 per cent by weight.
13. An incapacitant mixture according to any preceding claim, further comprising an alcohol.
14. An incapacitant mixture according to claim 13, wherein the proportion of alcohol is 25 per cent or less by weight.
15. An incapacitant mixture according to claim 14, wherein the proportion of alcohol is between 1.0 and 3.5 per cent by weight.
16. An incapacitant mixture according to claim 15, wherein the proportion of alcohol is
2.7 per cent by weight.
17. An incapacitant mixture according to any of claims 13 to 16, wherein the alcohol is selected from the group comprising ethanol, propanol and isopropanol.
18. An incapacitant mixture according to any preceding claim, comprising 0.3 per cent PAVA; a carrier being 72 per cent propylene glycol; 25 per cent water and 2.7 per cent ethanol, all by weight.
19. An incapacitant spray comprising means for storing and delivering an incapacitant mixture as defined in any of claims 1 to 18.
20. An incapacitant spray according to claim 19, wherein the means for delivering the incapacitant mixture comprises an aerosol propellant.
21. An incapacitant spray according to claim 20, wherein the propellant is selected from the group comprising nitrogen, carbon dioxide, 1,1,1,2-tetrafluoro ethane, dimethyl ether, butane, propane and oxygen.
22. An incapacitant spray according to claim 19, wherein the delivery means comprises a source of pressurised air to expel the mixture from the storing means.
23. An incapacitant spray according to any of claims 19 to 22, wherein the storing means is a can.
PCT/GB2008/050543 2007-07-05 2008-07-07 Improved incapacitant spray WO2009004390A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08776178A EP2176198B8 (en) 2007-07-05 2008-07-07 Improved incapacitant spray

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0713011.5 2007-07-05
GB0713011A GB0713011D0 (en) 2007-07-05 2007-07-05 Improved incapacitant spray

Publications (2)

Publication Number Publication Date
WO2009004390A2 true WO2009004390A2 (en) 2009-01-08
WO2009004390A3 WO2009004390A3 (en) 2009-02-26

Family

ID=38440415

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/050543 WO2009004390A2 (en) 2007-07-05 2008-07-07 Improved incapacitant spray

Country Status (3)

Country Link
EP (1) EP2176198B8 (en)
GB (2) GB0713011D0 (en)
WO (1) WO2009004390A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018185523A1 (en) * 2017-04-04 2018-10-11 Ledins Toms A defence spray and additive for water-cannons using iberverin as an ingredient
US20220244024A1 (en) * 2018-11-13 2022-08-04 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system
US11662182B2 (en) 2018-11-13 2023-05-30 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2000131A (en) * 1932-03-01 1935-05-07 Us Ordnance Engineers Inc Disabling and incapacitating gas generating chemical
US5217708A (en) * 1992-02-05 1993-06-08 Defense Technology Corporation Of America Capsicum lachrymator
DE69530062T2 (en) * 1995-01-24 2004-02-05 Defense Technology Corp. of America (n.d.Ges.d. Staates Delaware) Tear gas containing "capsaicinoid"
GB9710636D0 (en) * 1997-05-23 1997-07-16 Bauer Eran N Novel mixture
WO2006055640A2 (en) * 2004-11-19 2006-05-26 Mace Security International, Inc. Gel compositions
WO2006091561A1 (en) * 2005-02-22 2006-08-31 Mace Security International, Inc. Irritant-free gel compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018185523A1 (en) * 2017-04-04 2018-10-11 Ledins Toms A defence spray and additive for water-cannons using iberverin as an ingredient
US20220244024A1 (en) * 2018-11-13 2022-08-04 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system
US11650030B2 (en) * 2018-11-13 2023-05-16 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system
US11662182B2 (en) 2018-11-13 2023-05-30 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system
US11920906B2 (en) 2018-11-13 2024-03-05 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system
US11920907B2 (en) 2018-11-13 2024-03-05 David Daniel Rankin, Sr. Non-lethal defensive fluid composition and pressurized delivery system

Also Published As

Publication number Publication date
EP2176198A2 (en) 2010-04-21
GB2453013A (en) 2009-03-25
GB0812372D0 (en) 2008-08-13
EP2176198B1 (en) 2012-06-27
GB0713011D0 (en) 2007-08-15
EP2176198B8 (en) 2012-08-01
GB2453013B (en) 2012-12-05
WO2009004390A3 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
EP2176198B8 (en) Improved incapacitant spray
US5314097A (en) Long distance marking devices and related method
US5821450A (en) Incapacitating composition and a device for its use
JP2960445B2 (en) Aerosol composition
BR9810665A (en) Process for killing flying insects, and spraying device.
ES2340504T3 (en) AEROSOL.
US20100269762A1 (en) Animal Deterrent Apparatus
JP2001500397A (en) How to extinguish tank fires
US7334745B2 (en) Hazing a bird repellent solution
EP1249482A1 (en) Aerosol composition
US9277748B2 (en) Agonist/antagonist compositions and methods of use
US20030129138A1 (en) Non-lethal temporary incapacitation formulation and novel solvent system
RU2258076C2 (en) Method for temporary differentiation of controlling distances in sport and uses of foaming aqueous composition
US20040050557A1 (en) Fire engine trailer
US6524286B1 (en) Medical application system for animals
CN108137988A (en) Water proofing property plastic formulation
US5084097A (en) Aerosol spray for self protection and identification of assailants
US5286979A (en) Process for absorbing ultraviolet radiation using dispersed melanin
US20180051963A1 (en) Personal Safety Device
US4624389A (en) Method of personal self-defense
US6312701B1 (en) Pelargonic acid vanillyamide containing tear gas
EP0723948B1 (en) Capsaicinoid lachrymator
JPH0232190A (en) Aerosol product
RU2483051C2 (en) Liquid composition having irritant effect (versions)
WO2012074922A1 (en) Defense spray using isothiocyanate as an ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08776178

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008776178

Country of ref document: EP